A research article shows that Eradivir's patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies.
Read more …Eradivir's EV25 therapeutic reduces advanced-stage influenza viral loads faster, more thoroughly...

More Articles …